DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

Information source: University of Illinois at Chicago
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Subarachnoid Hemorrhage; Intracerebral Hemorrhage

Intervention: Nicardipine and Nipride (Drug)

Phase: N/A

Status: Completed

Sponsored by: University of Illinois at Chicago

Official(s) and/or principal investigator(s):
Ben Z Roitberg, MD, Principal Investigator, Affiliation: University of Illinois at Chicago, Department of Neurosurgery

Summary

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Clinical Details

Study design: Observational Model: Defined Population, Time Perspective: Longitudinal

Eligibility

Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 18-70 years old (inclusive)

- Admission to NSICU with a diagnosis of SAH or ICH

Exclusion Criteria:

- Patients who are admitted >48 hours after SAH or ICH

- Readmission or second SAH

- Readmission or second ICH

- Large (immediately life threatening) associated intraparenchymal or intraventricular

hemorrhage

- Women who are pregnant

Locations and Contacts

University of Illinois at Chicago, UIC, Chicago, Illinois 60612, United States
Additional Information

Starting date: June 2004
Last updated: June 21, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017